A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus

A Novel Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice from Pandemic H1N1 and Highly Pathogenic H5N1 Virus Challenges

(2013) R. Uraki et al.   JOURNAL OF VIROLOGY

A Replication-Incompetent PB2-Knockout Influenza A Virus Vaccine Vector

(2012) Sylvia T. Victor et al.   JOURNAL OF VIROLOGY

Current progress on development of respiratory syncytial virus vaccine

(2011) Jun Chang   BMB Reports

Replication-incompetent influenza A viruses that stably express a foreign gene

(2011) M. Ozawa et al.   JOURNAL OF GENERAL VIROLOGY

Taming influenza viruses

(2011) Makoto Ozawa et al.   VIRUS RESEARCH

Respiratory viruses and eosinophils: Exploring the connections

(2009) Helene F. Rosenberg et al.   ANTIVIRAL RESEARCH

Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus

(2009) R. Kohlmann et al.   JOURNAL OF VIROLOGY

Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses

(2009) Hsiao-Yun Shao et al.   VACCINE

Pulmonary Eosinophilia Is Attenuated by Early Responding CD8+ Memory T Cells in a Murine Model of RSV Vaccine-Enhanced Disease

(2009) Whitney W. Stevens et al.   VIRAL IMMUNOLOGY

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

(2008) Maria Florencia Delgado et al.   NATURE MEDICINE